This free webinar explored a comprehensive, patient-centred approach to HPV-related vulvar disease. Experts discussed the burden of vulvar pre-cancers and cancers, the role of HPV vaccination in prevention, practical approaches to treatment and preventing recurrence, and strategies for supporting sexual health, quality of life and long-term patient care.
Topics and Faculty:
The webinar aimed to help participants:
Marc Steben
Co-President·HPV Global Action
Dr. Marc Steben is a family doctor at the Family medicine Group la Cité du parc Lafontaine. He is president elect of the 2023 International Society for STD research. He is a member of the Board and chair for the Education Committee of the International Papillomavirus Society. He is chair of the Canadian Network for HPV Prevention. He is the elected president of the Canadian branch of the International Union Against STIs for 2023. He is a member of the Board of the American Sexual Transmitted Association. He is associate editor of the Journal of Obstetrics and Gynecology of Canada. He is professor at the School of Public Health at Université de Montréal. He is co-chairman of HPV Global Action. He is a member of the PAVE consortium of the National Cancer Institute of the American NIH.
Margaret Cruickshank
Professor, Obstetrics and Gynecology·University of Aberdeen, UK
Maggie Cruickshank has a personal chair in Gynaecology at the University of Aberdeen and is an Honorary Consultant Gynaecologist at Aberdeen Royal Infirmary. She is the Director of Research and Development for NHS Grampian. Her clinical practice focuses on lower genital tract disease and she is past President and a trustee of the British Society for Colposcopy and Cervical Pathology (BSCCP). She currently co-chairs the Education and Training Committee of the International Federation of Colposcopy and Cervical Pathology (IFCPC). Maggie has an interest in medical education and clinical training and leads to the training and assessment of colposcopy training for BSCCP and IFCPC.
Emma Allanson
A/Professor, Head of Department·Western Australian Gynaecologic Cancer Service
Associate Professor Emma Allanson is a gynaecologic oncologist and the head of the Western Australian Gynaecologic Cancer Service at King Edward Memorial Hospital in Perth, Western Australia. She completed her gynaecologic oncology fellowship in Australia, in addition to a research fellowship at MD Anderson Cancer Center in Houston Tx, and an editorial fellowship with the International Journal of Gynecological Cancer. A/Professor Allanson is the current chair of the ANZGOG ASM, the co-chair of the International Gynecologic Cancer Society Pre-invasive diseases committee, is on the Faculty of the IGCS Preinvasive program and the early career editorial board of the IJGC. She has a PhD in women's health in low and middle income countries, and her research interests are focused on the prevention and treatment of cervical cancer, and the follow up and survivorship care of women with endometrial cancer.
Joura Elmar
Associate Professor of Gynecology, Head of Colposcopy and Vulvar Services·Department of Obstetrics and Gynecology, Medical University of Vienna, General Hospital and Comprehensive Cancer Center Vienna
Elmar A. Joura, M.D., is Associate Professor of Gynecology and Obstetrics at the Medical University of Vienna, General Hospital (AKH), and Comprehensive Cancer Center Vienna, Austria Dr. Joura graduated from University of Graz, Austria where he subsequently worked at the Department of Pathological Anatomy. After internship of urology, surgery and internal Medicine, he started his training in Obstetrics and Gynecology, at the University of Vienna. Before he finished specialization, he worked for a period in Tanzania. Subsequently, he focused on gynecologic oncology and received a scholarship for a study leave at the National Women´s Hospital in Auckland, New Zealand. Since 1997 Dr. Joura is consultant gynecological oncologist and in 1998 he made his thesis on epithelial disorders of the vulva. Dr. Joura is head of the clinic for colposcopy and vulvar disease, is consultant for pelvic surgery and was involved in the development of different surgical techniques. Since 2001 Dr. Joura is investigator for the quadrivalent HPV vaccine trials, he has become member of publishing committee and the Global Advisory Board. He is also member of the Scientific Advisory Board and coordinating investigator for the ninevalent HPV vaccine. He was president of EUROGIN in 2016 (Salzburg). He is past president of the European college for the study of vulvovaginal disease (ECSVD). Dr. Joura has published more than 150 articles in peer- review journals and given more than 1000 lectures worldwide.